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CC BY-NC-ND license (http://creativeBackground: Central venous catheter (CVC) installation is essential for the treatment of crit-
ically ill neonates; however, it is associated with the development of neonatal intracardiac
thrombosis, which is a complication that is associated with a poor prognosis. We aimed to iden-
tify specific risk factors for the development of intracardiac thrombosis in the right atrium (RA)
and superior vena cava (SVC) related to the use of CVC in critically ill neonates.
Methods: A caseecontrol study was conducted at the tertiary referral neonatal intensive care
unit of the Pediatric Hospital Siglo XXI in Mexico City, Mexico from 2008 to 2013. The included
cases (nZ 43) were de novo patients with intracardiac thrombosis in the RA and SVC diagnosed
by echocardiography. The controls (nZ 43) were neonates without intracardiac thrombosis or
thrombosis at other sites. A logistic regression analysis was conducted, and odds ratios (ORs)
and 95% confidence intervals (95% CIs) were calculated.
Results: The independent risk factors for intracardiac thrombosis in the RA and SVC were the
surgical cut-down insertion technique (OR Z 2.98; 95% CI: 1.18e9.10), a maternal history of
gestational diabetes/diabetes mellitus (OR Z 10.64; 95% CI: 1.13e121.41), Staphylococcusnit in Clinical Epidemiology, Pediatric Hospital, The Siglo XXI National Medical Center, Mexican
uauhte´moc 330, Colonia Doctores, Delegacio´n Cuauhte´moc, Mexico City 06720, Mexico.
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Pediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
Risk factors for neonatal intracardiac thrombosis 289epidermidis infection (OR Z 7.09; 95% CI: 1.09e45.92), and CVC placement in the SVC
(OR Z 5.77; 95% CI: 1.10e30.18).
Conclusion: This study allowed us to identify several contributing factors to the development
of intracardiac thrombosis in the RA and SVC related to the installation of a CVC in a subgroup
of critically ill neonates. Multicenter and well-designed studies with a larger number of pa-
tients could help validate our findings and/or identify other risk factors that were not identi-
fied in the present study.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
The neonatal hemostatic system is well-balanced despite
its differences from the hemostatic systems of older chil-
dren and adults. However, it is not as well-balanced in
critically ill neonates, a subpopulation of neonates with an
increased risk of thrombosis due to certain conditions such
as prematurity, asphyxia, sepsis, dehydration, congenital
heart diseases, and other conditions.1e4 In particular,
intracardiac thrombosis in the right atrium (RA) and supe-
rior vena cava (SVC) has been associated with a high
endocarditis risk, sepsis persistence, pulmonary artery
obstruction, ventricular dysfunction, acute hemodynamic
compromise, and death.5e7 The use of a central venous
catheter (CVC) is an important risk factor for the devel-
opment of thrombosis at these sites, possibly due to direct
damage to the endocardium or endothelium caused by the
CVC.7,8 Neonatologists caring for critically ill neonates with
thrombosis at these sites are faced with two major chal-
lenges. Firstly, it is difficult to suspect the presence of
thrombosis in the RA and SVC because the signs include new
onset murmur, persistent sepsis, persistent thrombocyto-
penia, and cardiac failure, which are all unspecific.8 Sec-
ondly, the installation of a CVC is mandatory in these
patients in order to secure vascular access for the admin-
istration of specific medications, transfusions, and total
parenteral nutrition, which are important for the treatment
of these patients.5
To the best of our knowledge, specific risk factors for
CVC-related intracardiac thrombosis in the RA and SVC in
critically ill neonates have not been reported to date, and
most information on this topic has been obtained from case
report studies.6,7,9e11
2. Methods
A caseecontrol study was conducted between January 1,
2008 and December 31, 2013 using information from a
database at the Mexican Institute of Social Security that
contains all diagnoses of patients cared for at the Neonatal
Intensive Care Unit (NICU), Pediatric Hospital “Dr. Silvestre
Frenk Freund” of the Medical Unit of High Specialty, Siglo XXI
National Medical Center, Mexico City, Mexico to identify
patients diagnosed with intracardiac thrombosis during the
study period. The cases (n Z 43) were patients who devel-
oped intracardiac thrombosis in the RA and/or SVC after CVC
placement. For the control group, we randomly selected 43neonates from the NICU database who required the instal-
lation of a CVC during their stay, who had undergone at least
one echocardiogram a week from the date of CVC installa-
tion to hospital discharge, and who lacked evidence of
intracardiac thrombosis. Echocardiography was performed
by the pediatric cardiologist assigned to the NICU.
2.1. Data collection
Information on study variables and clinical data were
retrospectively collected from the clinical charts and
included the following: (1) sex; (2) corrected gestational
age (weeks of gestation); (3) birth weight (g); (4) reason for
admission to the NICU; (5) maternal history [pre-eclampsia,
diabetes (gestational or mellitus), placenta previa,
threatened abortion, preterm labor, and oligohydramnios];
(5) perinatal history (prematurity, low birth weight, and
perinatal asphyxia); (6) CVC-related factors (catheter type,
catheter material, catheter size, lumen number, insertion
site, catheter tip location, placement method, and CVC
placement duration in days); (7) variables related to total
parenteral nutrition (TPN) (number of days and osmolarity);
(8) documented infection by blood culture; (9) the pres-
ence and type of congenital heart disease; (10) cardiac
surgery (yes/no); (11) thrombocytopenia (< 150,000/mm3);
(12) the location and size of the intracardiac thrombosis;
and (13) transfusions through the CVC (yes/no). For the
cases, patients were considered positive for a risk factor
only if it was documented prior to the diagnosis of intra-
cardiac thrombosis in the RA or SVC.
2.2. Statistical analysis
Dichotomous and categorical variables were compared be-
tween the cases and controls using the Chi-square test and/
or Fisher’s exact test, as appropriate. Continuous variables
were compared between groups using Student t test. The
variables in the bivariate analysis that were clinically and
statistically significant (p < 0.1) were introduced into the
final unconditional logistic regression model. Odds ratios
(ORs) and 95% confidence intervals (95% CIs) were
calculated.
3. Results
The annual incidence of intracardiac thrombosis in the RA
and/or SVC in the NICU of the Pediatric Hospital “Dr.
Table 2 Type of congenital heart disease.
Type of congenital heart disease Cases Controls
n % n %
Patent ductus arteriosus 12 27.9 6 13.9
Hypoplastic left heart syndrome 2 4.6 2 4.6
Double outlet right ventricle 1 2.3 3 7.0
Anomalous pulmonary venous
connection
1 2.3 3 7.0
Atrial septal defect 1 2.3 d d
Ventricular septal defect d d 2 4.6
Complete atrioventricular block 1 2.3 d d
Coarctation of the aorta 1 2.3 d d
Tricuspid and pulmonary atresia d d 2 4.6
Hypoplastic right heart syndrome d d 1 2.3
Without congenital heart disease 24 56.0 24 56.0
Total 43 100 43 100
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rate was calculated as the 43 cases who developed
thrombosis in the RA and/or SVC during the 6 years of the
study divided by the number of neonates with a CVC who
attended the NICU during the same period (n Z 1910). In
the case group, a total of 22 (51.2%) patients were boys, the
mean corrected gestational age was 32.4 weeks (95% CI:
31.1e33.6 weeks), and the mean weight was 1713.6 g (95%
CI: 1439.8e1987.4 g). No statistically significant differences
between the cases and controls were observed for these
variables (Table 1). In addition, the cases that were most
frequently premature (< 37 weeks of gestation; pZ 0.01),
had a low birth weight (< 1500 g; p Z 0.04) and had a
history of perinatal asphyxia (pZ 0.04) compared with the
controls.
Moreover, congenital heart diseases were the main di-
agnoses at admission to the NICU, and the patent ductus
arteriosus was the most frequent type of congenital heart
disease, affecting 27.9% (nZ 12) and 13.9% (nZ 6) of cases
and controls, respectively (Tables 1 and 2). Of note, neither
the cases nor the controls had thrombosis in vessels other
than the SVC or in other parts of the body.Table 1 Clinical characteristics of cases and controls.
Variables Cases
(n Z 43)
Controls
(n Z 43)
p
Sex
Boys 22 (51.2) 26 (60.5) 0.38y
Girls 21 (48.8) 17 (39.5)
Corrected gestational age (wk)
Mean 32.4 34.8 0.56z
95% CI 31.1e33.6 33.4e36.1
Birth weight (g)
Mean 1713.6 2101.3 0.37z
95% CI* 1439.8e1987.4 1812.7e2389.9
Reasons for admission to the NICU
Congenital heart
disease
19 (44.1) 19 (44.1) 0.50
Necrotizing
enterocolitis
7 (16.3) 2 (4.7) 0.92
Airway injury 4 (9.3) 1 (2.3) 0.28
Hypoxic ischemic
encephalopathy
3 (7.0) 1 (2.3) 0.85
Gastroschisis 1 (2.3) 3 (7.0) 0.12
Intestinal
malformation
1 (2.3) 3 (7.0) 0.12
Other conditionsx 8 (18.7) 14 (32.6) 0.14
Data are presented as n (%).
CIZ confidence interval; NICUZ neonatal intensive-care unit.
* Confidence interval at 95%.
y Chi-square test/Fisher’s exact test when appropriate.
z Student t test.
x Other diseases included inborn errors of metabolism, hypo-
tonia, meconium ileus; pulmonary malformation, sepsis, hem-
orrhagic disease of the newborn, dysmorphic syndrome,
congenital glaucoma, diaphragmatic hernia, Chiari malforma-
tion type 2, esophageal atresia, and vertebral anomalies, anal
atresia, cardiac defects, tracheoesophageal fistula and/or
esophageal atresia, renal and radial anomalies, and limb de-
fects (VACTERL association disorder).Regarding the location and size of the thrombi in the
case group, 39.5% (n Z 17) of patients had a thrombus in
the RA or SVC, and a small proportion of patients had a
thrombus in both the SVC and RA; the majority of the
thrombi were < 2 cm in size (Table 3). The CVC tip was
predominantly located in the right atrium in the cases
(46.7%) and the controls (53.3%). However, the CVC tip was
located in the SVC in a greater proportion of cases (72.7%)
than controls (27.3%). A bivariate analysis was used to
evaluate whether the type of catheter (ARROW, EB-PICC, or
BIOFLUX) was associated with an increased risk for devel-
oping thrombosis in the RA and/or SVC, but a statistically
significant relationship was not observed (Table 4).
In the study population, the majority of the CVCs were
of polyurethane material, were 4 French in size with two
lumens, and were placed using the surgical cut-down
method. The surgical cut-down method of placement was
more frequently used in the cases than in the controls
(p < 0.01). TPN, with a duration of at least 7 days, was
required for almost all cases and controls (Table 4). Os-
molarity and duration of TPN were not associated with a
high risk of thrombosis in the RA or SVC.
After bivariate analysis, significant variables (p  0.1;
Table 4) were included in a logistic regression analysis.Table 3 Location and size of intracardiac thrombosis in
critically ill newborns cared for at the neonatal intensive-
care unit during the study period.
Characteristics of intracardiac thrombus n %
Location of thrombus
Superior vena cava 17 39.5
Right atrium 17 39.5
Superior vena cava and right atrium 9 21.0
Total 43 100
Thrombus size (cm)
<1 19 44.1
1e2 15 34.9
>2 9 21.0
Total 43 100
Table 4 Results of the bivariate analysis of maternal,
perinatal, catheter-specific, and other risk factors for
intracardiac thrombosis in the right atrium in critically ill
neonates who required the installation of a central venous
catheter.
Variables Cases
(n Z 43)
Controls
(n Z 43)
p*
Maternal history
Pre-eclampsia 12 (63.2) 7 (36.8) < 0.01
Gestational diabetes/
diabetes mellitusy
5 (83.3) 1 (16.7) 0.02
Placenta previa/
placental abruption
5 (83.3) 1 (16.7) 0.02
Threatened abortion 6 (85.7) 1 (14.3) 0.01
Preterm labor 3 (50.0) 3 (50.0) 0.25
Oligohydramnios 2 (50.0) 2 (50.0) 0.33
Perinatal history
Prematurity (<37 WOG) 34 (59.6) 23 (40.4) 0.01
Low birth weight
(<1500 g)
23 (62.2) 14 (37.8) 0.04
Perinatal asphyxia 22 (62.9) 13 (37.1) 0.04
Factors related to the CVC
Catheter tip location
Superior vena cava 8 (72.7) 3 (27.3) 0.09
Right atrium 35 (46.7) 40 (53.3) d
Type of catheter
ARROW percutaneous 30 (46.9) 34 (53.1) 0.51
EB-PICC percutaneous 7 (53.8) 6 (46.2) 0.29
BIOFLUX 6 (66.7) 3 (33.3) 0.76
Catheter material
Polyurethane 37 (50.0) 37 (50.0) 0.62
Silicone 6 (50.0) 6 (50.0) d
Size of catheter (Fr)
2 7 (58.3) 5 (41.7) 0.37
4 34 (47.2) 38 (52.8) d
No. of CVC lumens
1 6 (53.8) 6 (46.2) 0.62
2 37 (50.0) 37 (50.0) d
Method of placement
Surgical cut-down 35 (60.3) 23 (39.7) <0.01
Puncture 8 (28.6) 20 (71.4) d
Duration of CVC placement (d)
>7 42 (49.4) 43 (50.6) 0.50
>14 37 (46.3) 43 (53.8) 0.01
>21 28 (40.6) 41 (59.4) <0.01
Factors related to TPN
Duration of TPN (d)
> 7 37 (54.4) 31 (45.6) 0.09
> 14 23 (46.0) 27 (54.0) 0.25
> 21 20 (62.5) 12 (37.5) 0.07
> 30 5 (38.5) 8 (61.5) 0.27
Osmolarity of the TPN (mOsm/L)
>900 38 (49.4) 39 (50.6) 0.50
>1000 38 (49.4) 39 (50.6) 0.50
>1300 29 (45.3) 35 (54.7) 0.11
Other factors
Documented infectiony
Staphylococcus
epidermidis
9 (81.8) 2 (18.2) 0.02
Table 4 (continued )
Variables Cases
(n Z 43)
Controls
(n Z 43)
p*
Other Staphylococciz 3 (60.0) 2 (40.0) 0.38
Other bacteriax 12 (54.5) 10 (45.5) 0.24
Transfusions through the CVC 28 (46.7) 32 (53.3) 0.24
Data are presented as n (%).
CVC Z central venous catheter; TPN Z total parenteral nutri-
tion; WOG Z weeks of gestation.
* Chi-square test or Fisher’s exact test when appropriate.
y Patient infection documented by blood culture conducted
previous to thrombus detection.
z Other Staphylococci: S. aureus and S. hominis.
x Other bacteria: Klebsiella pneumoniae, Pseudomonas aer-
uginosa, Enterobacter cloacae, Serratia marcescens, Entero-
coccus faecalis, Enterobacter asburiae, and Moraxella sp.
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high correlations (above 0.3) between prematurity, low
birth weight, and CVC location, and between threatened
abortion and Staphylococcus epidermidis infection. There-
fore, we eliminated the prematurity and threatened abor-
tion variables from the final logistic regression analysis in
order to avoid the homoscedasticity phenomenon.12
The following were independent risk factors for the
development of RA and SVC thrombosis: (1) a maternal
history of gestational diabetes/diabetes mellitus
(OR Z 10.64; 95% CI: 1.13e121.41); (2) the surgical cut-
down insertion technique (OR Z 2.98; 95% CI: 1.18e9.10);
(3) placement of the CVC in the SVC (OR Z 5.77; 95% CI:
1.10e30.18); and (4) S. epidermidis infection (OR Z 7.09;
95% CI: 1.09e45.92).
In our study, a total of 10 (23.2%) patients with throm-
bosis in the RA and/or SVC died during their stay in the
NICU. In this subgroup, a sex predominance was not
observed (50% boys/50% girls), and seven patients were
premature.
The following morbidities were reported after the date
of thrombosis diagnosis in the patients who died: (1)
persistence of sepsis (n Z 3); (2) ventricular dysfunction
(nZ 2); (3) acute renal failure (nZ 3); and (4) endocarditis
(n Z 1). The direct causes of mortality (according to the
reported in death certificates) were the following: (1)
septic shock (nZ 7); (2) cardiogenic shock (nZ 2); and (3)
multiple organ failure (n Z 1).4. Discussion
The presence of central venous and arterial catheters is the
greatest acquired risk factor for the development of post-
natal thromboembolic events in neonates.5,13,14 To the best
of our knowledge, we are the first to identify risk factors for
the development of intracardiac RA and SVC thrombosis in a
subpopulation of critically ill neonates who required the
installation of a CVC.
We observed a high incidence of intracardiac thrombosis
in the RA and SVC, with approximately 22.5 cases per 1000
admissions to the NICU, considering that the reported
incidence of general thrombotic events in the prospective
292 A. Ulloa-Ricardez et alCanadian registry is 2.4 cases per 1000 NICU admissions.5
One possible explanation for the high incidence of this
type of thrombosis in our study compared with previous
reports is that our NICU is at a tertiary level pediatric
hospital in Mexico City, and only critically ill neonates are
admitted to our NICU; those patients are a subpopulation of
neonates considered to be at high risk for the development
of thrombosis due to an imbalance between the pro- and
anticoagulant responses of the hemostatic system.1e4 Pa-
tients admitted to our NICU have severe diseases, such as
complex congenital heart defects, and they require highly
specialized surgery, are preterm or extremely preterm,
have diseases with important hemodynamic compromise,
etc. Furthermore, all of these patients require the instal-
lation of a CVC to provide a vascular access for parenteral
nutrition support, administration of inotropic medications
with a high osmolarity, transfusions, and other treatments.
However, it is important to note that the true incidence
of intracardiac thrombosis in the RA and SVC in critically ill
neonates who require the installation of a CVC has not been
precisely reported, and data on this topic are limited to
case reports.11 This lack of data may be due to the difficulty
of diagnosing thrombosis at these sites and to the fact that
the majority of cases are asymptomatic. Therefore, this
issue could be solved by performing an intentional pro-
spective search for thrombi at these sites (RA and SVC) by
systematically performing echocardiograms after CVC
placement.3
In the present study, the most important diagnosis in
cases and controls at admission to the NICU was congenital
heart disease, followed by necrotizing enterocolitis, intes-
tinal malformation, gastroschisis, hypoxic ischemic en-
cephalopathy, and airway injury. The congenital cardiac
problems that were observed most frequently were
persistence of ductus arteriosus with hemodynamic reper-
cussion, hypoplastic left heart syndrome, double outlet
right ventricle, anomalous pulmonary venous connection,
and others. It has been reported that presenting primarily
with cyanotic congenital heart disease and undergoing
cardiac surgery both increase the risk of neonatal throm-
bosis by producing hyperviscosity and surgical trauma,
respectively.6,14,15 However, in the present study, no asso-
ciation was observed between cyanotic congenital heart
disease (pZ 0.35) or undergoing cardiac surgery (pZ 0.25)
and an increased risk of thrombosis in the RA and SVC.
We found a positive association between prematurity
and the development of thrombosis in the RA and SVC in
critically ill newborns (p Z 0.01; Table 4). This finding is
consistent with previous reports in the literature stating
that ill preterm neonates are at high risk of thrombotic
events because of the combination of a high prothrombotic
activity, low levels of natural anticoagulants, and various
imbalances in the fibrinolytic system.15,16
Furthermore, we observed that a maternal history of
gestational diabetes/diabetes mellitus is an independent
risk factor for the development of thrombosis in the RA and
SVC in newborns. One of the proposed mechanisms of the
influence of maternal factors on the development of
thrombosis in the newborn is the interaction between
maternal and fetal circulation during gestation, which re-
sults in the activation of endothelial coagulation, vascular
damage, inflammation of the placental blood vessels,vasospasm, and vasoconstriction in the mother increasing
the risk of neonatal thrombosis.1,14e17
Interestingly, when the surgical cut-down technique was
used for CVC placement instead of the puncture technique,
an increased risk of developing thrombosis in the RA and
SVC was noted. This could be the result of major manipu-
lation of the blood vessels with the surgical cut-down
technique compared with the puncture technique.18 In
keeping with Virchow’s triad, surgical cut-down may cause
more blood stasis, hypercoagulability, and vascular injury,
subsequently leading to the development of a thrombus
near the site of catheter insertion.19e23 Of note, in a high
proportion of cases with thrombus in the SVC (72.7%), the
tip of the CVC was also located in the SVC (Table 4).
Moreover, the location of the CVC tip in the SVC was also an
independent risk factor for thrombosis in logistic regression
analysis. In this regard, CVC tip location is an important
factor related to thrombus formation, mainly by causing
direct endothelial damage.24e26 According to previous
studies, we expected that the CVC tip being located in the
RA was a risk factor for the development of intracardiac
thrombosis in the RA; however, this was not observed in the
present study.27,28
The time of administration of TPN and its osmolarity
have been reported as important risk factors for thrombosis
in other parts of the body in children,11,19,29 but these
factors were not identified as risk factors in the present
study. This finding was most likely because the subgroup of
neonates studied here were critically ill with hemodynamic
instability, cardiogenic shock, and associated infections,
which at any given moment, could be absolute indications
for modification or withdrawal of TPN.
It is well known that infection is among the factors
associated with an increased risk of thrombosis through the
provocation of impaired fibrinolysis in the anticoagulation
system and/or blood circulation.30e34 In the present study,
S. epidermidis infection was another important risk factor
for thrombosis in the RA and SVC. This finding can be
explained by the fact that S. epidermidis and other Gram-
positive bacteria have a high potential to induce throm-
bosis.35 One of the most recently described mechanisms of
this activity is the ability of S. epidermidis to bind to
platelets, which promotes platelet aggregation.36
4.1. Morbidity and mortality of neonates with
thrombosis in the RA and/or SVC
In our study, almost one quarter of the patients with
intracardiac thrombosis in the RA and/or SVC died despite
receiving treatment with alteplase and/or enoxaparin at
conventional doses. They developed complications, such as
ventricular dysfunction, persistence of sepsis, acute renal
failure, and endocarditis. All of these complications have
been reported to be associated with poor prognosis in pa-
tients with intracardiac thrombosis.27,37,38
4.2. Limitations of this study
A limitation of the present study is its retrospective nature.
As information about exposure was collected from recorded
information, it is susceptible to information bias and relies
Risk factors for neonatal intracardiac thrombosis 293on the completeness and accuracy of the recorded infor-
mation. However, this limitation could be resolved by
conducting prospective studies. In addition, weekly echo-
cardiography was not routinely performed for every
neonate with CVC; therefore, the actual sample size could
have been underestimated because some cases with
thrombi may not have had clinical symptoms or signs.
Secondly, the control group was small, resulting in the
study findings having low statistical power. In regard to the
selection of our controls, it is possible to have selection bias
by choosing them randomly; a proper control group should
include all neonates with CVCs without thrombus.4.3. Conclusion
To the best of our knowledge, this is the first study to report
that the surgical cut-down insertion technique, a maternal
history of gestational diabetes/diabetes mellitus, S. epi-
dermidis infection, and the CVC tip being located in the
SVC are contributing factors to the development of intra-
cardiac thrombosis in the RA and SVC in critically ill neo-
nates who required the installation of a CVC. Finally, taking
into account that intracardiac thrombosis is a rare event in
neonates, we believe that well-designed multicenter
studies would help validate our findings and/or help iden-
tify other risk factors of thrombosis in the RA and SVC that
were not observed in the present study.Conflicts of interest
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